fludarabine has been researched along with Pemphigus in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Cao, L; Du, XY; Fan, L; Li, JY; Wang, F; Wang, L; Xu, W; Zhu, HY | 1 |
Albert, S; Bhogal, B; Black, MM; Oyama, N; Powell, AM; Sakuma-Oyama, Y | 1 |
Creamer, D; Devereux, S; Mufti, G; Perera, GK; Salisbury, J | 1 |
Anhalt, GJ; Cummins, DL; Meyerle, JH; Mimouni, D; Owens, N; Tzu, J | 1 |
Hashimoto, T; Hull, CM; Ishii, N; Leiferman, KM; Taintor, AR; Zone, JJ | 1 |
Antonov, M; Buyukunal, E; Demirkesen, C; Kursunoglu, SG; Ozguroglu, M; Serdaroglu, S; Turna, H; Yanmaz, MT; Yildiz, O | 1 |
Bachelez, H; Bazarbachi, A; Dehen, L; Delmer, A; Dubertret, L; Zittoun, R | 1 |
Blaschke, V; Braess, J; Brinck, U; Dames, K; Letschert, M; Neumann, C; Reich, K; Rünger, TM; Wörmann, B | 1 |
Allen, J; Amagai, M; Carmichael, AJ; Dean, D; Frith, P; Gooptu, C; Hashimoto, T; Littlewood, TJ; Lyon, CC; MacWhannell, A; Oliwiecki, S; Wojnarowska, F | 1 |
1 review(s) available for fludarabine and Pemphigus
Article | Year |
---|---|
Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans.
Topics: Aged; Biopsy, Needle; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mycophenolic Acid; Paraneoplastic Syndromes; Pemphigus; Risk Assessment; Severity of Illness Index; Stomatitis; Treatment Outcome; Vidarabine | 2004 |
8 other study(ies) available for fludarabine and Pemphigus
Article | Year |
---|---|
Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vidarabine | 2020 |
PNP with Waldenström's macroglobulinaemia.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Drug Eruptions; Fatal Outcome; Humans; Male; Paraneoplastic Syndromes; Pemphigus; Skin Neoplasms; Vidarabine; Waldenstrom Macroglobulinemia | 2005 |
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; B-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esophageal Diseases; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Cellular; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Lichenoid Eruptions; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mucositis; Paraneoplastic Syndromes; Pemphigus; Prednisone; Recurrence; Rituximab; T-Lymphocytes; Vidarabine; Vincristine | 2007 |
A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Paraneoplastic Syndromes; Pemphigus; Rituximab; Vidarabine | 2007 |
Paraneoplastic pemphigus associated with fludarabine use.
Topics: Antineoplastic Agents; Humans; Immunoglobulin G; Keratinocytes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Vidarabine | 2007 |
Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine.
Topics: Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Vidarabine | 1995 |
Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus.
Topics: Adult; CD8-Positive T-Lymphocytes; Drug Eruptions; Epidermis; Female; Histocompatibility Antigens Class II; Humans; Immunohistochemistry; Immunophenotyping; Immunosuppressive Agents; In Situ Nick-End Labeling; Intercellular Adhesion Molecule-1; Lymphoma, Non-Hodgkin; Pemphigus; Reverse Transcriptase Polymerase Chain Reaction; Vidarabine | 1999 |
Paraneoplastic pemphigus: an association with fludarabine?
Topics: Antineoplastic Agents; Drug Eruptions; Fatal Outcome; Fluorescent Antibody Technique; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Vidarabine | 2001 |